Increasing but conflicting studies indicate that SLC34A2 has a critical role in lung cancer: Kiyamova et al.10 and Kopantzev et al.11 reported decreased expression of SLC34A2 in NSCLC comparing with corresponding normal tissue. The gene discussed is SLC34A2; the disease is lung carcinoma.